Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report)’s share price reached a new 52-week high during trading on Wednesday . The stock traded as high as $271.32 and last traded at $271.5990, with a volume of 1891804 shares. The stock had previously closed at $244.26.
Key Stories Impacting Astera Labs
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Evercore ISI and other Wall Street firms have turned more constructive on Astera Labs (ALAB), with higher price targets and buy/outperform-style ratings helping fuel momentum and pushing the stock to fresh highs. Article Title
- Positive Sentiment: Investors are betting that Astera Labs will benefit from the ongoing AI infrastructure and AI inference boom, since its connectivity chips are used in data-center and cloud systems that support advanced processors and accelerators. Article Title
- Positive Sentiment: Recent articles point to record-high trading and strong bullish order flow, including elevated call-option activity and a “Power Inflow” signal, which can attract momentum traders and support further near-term upside. Article Title
- Neutral Sentiment: Several executives, including the CEO, COO, and general counsel, disclosed stock sales. The company said some sales were made under pre-arranged Rule 10b5-1 plans or for tax withholding, so the moves are not necessarily a negative operating signal. Article Title
Wall Street Analyst Weigh In
Several equities analysts have issued reports on ALAB shares. Stifel Nicolaus boosted their price objective on shares of Astera Labs from $236.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. UBS Group began coverage on shares of Astera Labs in a report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 target price on the stock. Rothschild & Co Redburn initiated coverage on shares of Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 price target on the stock. Evercore reissued an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a report on Tuesday. Finally, Needham & Company LLC raised their price objective on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $233.75.
Astera Labs Price Performance
The company has a 50-day moving average of $166.74 and a two-hundred day moving average of $158.75. The stock has a market capitalization of $51.05 billion, a PE ratio of 201.24, a P/E/G ratio of 3.81 and a beta of 3.35.
Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. During the same quarter in the prior year, the business posted $0.33 earnings per share. Astera Labs’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts forecast that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.
Insider Transactions at Astera Labs
In other news, Director Stefan A. Dyckerhoff sold 3,505 shares of Astera Labs stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $200.03, for a total value of $701,105.15. Following the transaction, the director directly owned 63,639 shares of the company’s stock, valued at $12,729,709.17. The trade was a 5.22% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 14,076 shares of the business’s stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $231.78, for a total value of $3,262,535.28. Following the sale, the general counsel owned 104,139 shares of the company’s stock, valued at $24,137,337.42. The trade was a 11.91% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 1,915,461 shares of company stock worth $358,508,976 in the last three months. 12.50% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of ALAB. Nordea Investment Management AB acquired a new position in shares of Astera Labs during the fourth quarter worth about $2,028,000. Geneva Partners LLC purchased a new stake in shares of Astera Labs during the 3rd quarter valued at about $1,876,000. Numerai GP LLC raised its holdings in shares of Astera Labs by 153.1% during the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after buying an additional 7,992 shares during the period. Handelsbanken Fonder AB lifted its position in Astera Labs by 289.5% during the 3rd quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock worth $24,710,000 after acquiring an additional 93,800 shares in the last quarter. Finally, Paragon Advisors LLC purchased a new position in Astera Labs in the 3rd quarter worth approximately $1,829,000. 60.47% of the stock is owned by institutional investors and hedge funds.
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Further Reading
- Five stocks we like better than Astera Labs
- Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half
- Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish
- Intuit’s Great SaaS Reset: Fired By AI
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
